Appleton Coated Green Power no Longer Green-e Certified

Civil, mechanical, industrial, chemical, electrical, naval, forest, and software - for JDI, the skills of our 1000+ engineers and engineer technologists are vital to our continued growth, modernization, and improvement. To promote the profession and showcase our team, we are profiling some of the many valued engineers across our operations. We asked what advice they’d give to an engineer just starting out and what sparked their interest in the profession.

As part of optimising the Rottneros Group, a new organisation is introduced with a group-wide sales organisation and a site manager for each mill. At the same time, a group-wide safety function is established, which becomes part of the Human Resource Department. The purpose of the new organisation is to create an increased focus within each sub-area. Through the new organisation, the mills can focus wholeheartedly on productivity, quality, environment, costs and completion of Agenda 500. The common safety function also means that we will be able to get even more out of our high-priority safety work in the future, while it can be conducted in an efficient way, comments Lennart Eberleh, President and CEO of Rottneros. Click Read More below for additional information.

UPM Biomedicals is excited to announce its collaboration with bioconvergence company CELLINK. The partnership brings together UPM’s expertise for producing non-animal derived, nanocellulose biomaterials with CELLINK’s years of experience in method development for 3D bioprinting, offering new groundbreaking solutions to this growing life sciences market. Advances in 3D printing in the past decade have been outstanding, and the technology is becoming more widely used for various cutting-edge applications. 3D bioprinting is already important in areas such as cancer research, where tumour models can be printed to test their response to different treatments. More recently scientists have been exploring the use of this technology in a clinical setting, with the possibility of printing tissues or organs that can then be transplanted into patients. Using non-animal derived raw materials, such as UPM’s nanofibrillar cellulose, for bio-ink formulations makes transplants into humans much more effective, reducing the possibility of an immune response or rejection.